A Physiologically Responsive Nanocomposite Hydrogel for Treatment of Head and Neck Squamous Cell Carcinoma via Proteolysis‐Targeting Chimeras Enhanced ImmunotherapyYaping Wu, Shuyang Sun, Xiaowei Chang et al.|Advanced Materials|2023Cited by 117
Pharmacogenomic landscape of head and neck squamous cell carcinoma informs precision oncology therapyZiyue Gu, Shuyang Sun, Yanli Yao et al.|Science Translational Medicine|2022Cited by 88
Single-cell and spatial dissection of precancerous lesions underlying the initiation process of oral squamous cell carcinomaLulu Sun, Shuyang Sun, Xindan Kang et al.|Cell Discovery|2023Cited by 77
Clinical utility of PDX cohorts to reveal biomarkers of intrinsic resistance and clonal architecture changes underlying acquired resistance to cetuximab in HNSCCYanli Yao, Shuyang Sun, Yujue Wang et al.|Signal Transduction and Targeted Therapy|2022Cited by 40
Atherosclerosis: The Involvement of Immunity, Cytokines and Cells in Pathogenesis, and Potential Novel TherapeuticsChang Su, Junnan Tang, Jinying Zhang et al.|Aging and Disease|2022Cited by 26